Among approved drugs, tirzepatide (Mounjaro/Zepbound) produced the largest average weight loss in trials, about 20.9% over 72 weeks at the highest dose in SURMOUNT-1, ahead of semaglutide at roughly 14.9% over 68 weeks in STEP 1
Supresin de glucagn : Reduce la liberacin de glucagn, una hormona que aumenta la glucosa en sangre, ayudando a prevenir picos glucmicos despus de las comidas
However, liver enzyme normalization does not necessarily indicate resolution of inflammation or fibrosis
FDA.gov (2026) 12
Let me know how you get on Hey Minniemouse
Following your initial consultation, Melanie Speed, APRN, NP-C, CANS, will likely recommend follow-up appointments once a month to track your progress and adjust your dosage if necessary